Skip to main content
. 2021 Sep 1;154(3):335–344. doi: 10.1007/s11060-021-03832-5

Table 1.

General patient characteristics

General characteristics All patients Group I (age: ≤ 64 yrs) Group II (age: ≥ 65 yrs) Subgroup IIa (age: 65–69 yrs) Subgroup IIb (age: 70–79 yrs) Subgroup IIc (age: ≥ 80 yrs)
No. % No. % No. % No. % No. % No. %
No. of patients 768 100 484 63 284 37 101 13.1 142 18.7 41 5.3
Age (median) 60 53 72 67 73 83
Sex
 Female 579 75.4 376 77.7 203 71.5 70 69.3 102 71.5 31 75.6
 Male 189 24.6 108 22.3 81 28.5 31 30.7 40 28.5 10 24.4
Tumor size
 1–3 cm 252 32.8 170 35.1 82 28.9 35 34.7 36 25 11 26.8
 3–6 cm 233 30.3 137 28.3 96 33.8 24 23.8 57 39.6 16 39
 6–10 cm 61 7.9 37 7.6 24 8.5 6 5.9 12 8.3 6 14.6
 10–15 cm 3 0.4 2 0.4 1 0.4 1 0.7
 > 20 cm 1 0.1 1 0.4 1 2.4
 NK 218 28.4 138 28.5 80 28.2 36 35.6 38 26.4 7 17.1
Brain edema
 None 380 49.5 259 53.5 121 42.6 53 52.5 62 43.1 7 17.1
 Moderate 190 24.7 113 23.3 77 27.1 20 19.8 39 27.1 19 46.3
 Large 148 19.3 75 15.5 73 25.7 20 19.8 39 27.1 14 34.1
 NK 50 6.5 37 7.6 13 4.6 8 7.9 4 2.8 1 2.4
Asymptomatic meningioma 73 9.5 50 10.3 23 8.1 11 10.9 13 9

NK not known, yrs years